Ardent Health Partners, LLC (ARDT) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $9.42. It has a SharesGrow Score of 75/100, indicating a strong investment profile with 5 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ARDT = $47.37 (+402.9% from the current price, the stock appears undervalued). Analyst consensus target is ARDT = $14 (+50.1% upside).
Valuation: ARDT trades at a trailing Price-to-Earnings (P/E) of 9.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.98.
Financials: revenue is $6.3B, +7.2%/yr average growth. Net income is $136M, growing at +69.8%/yr. Net profit margin is 2.1% (thin). Gross margin is 97.5% (+16.1 pp trend).
Balance sheet: total debt is $2.3B against $1.7B equity (Debt-to-Equity (D/E) ratio 1.34, moderate). Current ratio is 1.97 (strong liquidity). Debt-to-assets is 42.8%. Total assets: $5.3B.
Analyst outlook: 8 / 12 analysts rate ARDT as buy (67%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 96/100 (Pass), Growth 83/100 (Pass), Past 100/100 (Pass), Health 67/100 (Partial), Moat 74/100 (Pass), Future 73/100 (Pass), Income 30/100 (Fail).
